Theranos Scrutiny Shows FDA's Murky Oversight Of Lab Tests
By Sindhu Sundar ( October 30, 2015, 4:27 PM EDT) -- The U.S. Food and Drug Administration dealt health-testing startup Theranos Inc. a setback with an inspection report designating its signature thumbtack-size blood sample vial an "uncleared medical device," in a case that highlights the unclear status of laboratory-developed tests while the FDA considers its proposal for introducing new regulations for the testing industry....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.